Literature DB >> 34121396

Participation of Mind Bomb-2 in Sevoflurane Anesthesia Induces Cognitive Impairment in Aged Mice via Modulating Ferroptosis.

Lili Zhao1, Haixia Gong1, Haijin Huang1, Gulisitan Tuerhong1, Haimei Xia1.   

Abstract

Postoperative cognitive dysfunction (POCD) is a complication of the central nervous system (CNS) often occurred after surgery or anesthesia in the elder patients. Mind bomb-2 (MIB2) has been reported to modulate neuronal functions. Here, we aimed to study whether MIB2 exerts roles in the effects of sevoflurane anesthesia on mice hippocampal neurons and function, and how. Aging male C57BL/6 mice were subjected to sevoflurane administration, and primary hippocampal neurons were adopted to study sevoflurane effects in vitro. Western blotting and immunohistochemistry assay were used to study the protein expression of MIB2. CCK-8 assay and propidium iodide (PI) staining were performed to evaluate cell viability and cell death, respectively. Ferroptosis-related indicators malondialdehyde (MDA), glutathione (GSH), and iron levels were checked through indicated ELISA kits. Co-immunoprecipitation was adopted to study the binding effects of MIB2 to GPX4. We found that sevoflurane anesthesia increased MIB2 expression in mice hippocampus tissues and neurons. Knockdown of MIB2 alleviated neuron death and ferroptosis induced by sevoflurane exposure. Downregulated MIB2 enhanced GPX4 stability and reduced its ubiquitination. MIB2 was verified to bind to GPX4. The effects of MIB2 knockdown on the neuron death and ferroptosis can be reversed by further siGPX4 transfection. In vivo results also showed that MIB2 knockdown reduced hippocampal neuron death, ferroptosis, and cognitive impairments in the sevoflurane-exposed mice. Taking all together, downregulation of MIB2 could alleviate the sevoflurane-anesthesia-induced cognitive dysfunction and neuron injury through reducing ferroptosis via GPX4. Our results also provide novel directions for POCD treatment using anti-MIB2-related drugs or strategies.

Entities:  

Keywords:  MIB2; POCD; anesthesia; ferroptosis; neuron; sevoflurane

Year:  2021        PMID: 34121396     DOI: 10.1021/acschemneuro.1c00131

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  6 in total

Review 1.  The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis.

Authors:  Yixuan Zhang; Mingrui Li; Yiming Guo; Shuang Liu; Yongguang Tao
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

2.  Ubiquitin-Specific Protease 2 in the Ventromedial Hypothalamus Modifies Blood Glucose Levels by Controlling Sympathetic Nervous Activation.

Authors:  Mayuko Hashimoto; Masaki Fujimoto; Kohtarou Konno; Ming-Liang Lee; Yui Yamada; Koya Yamashita; Chitoku Toda; Michio Tomura; Masahiko Watanabe; Osamu Inanami; Hiroshi Kitamura
Journal:  J Neurosci       Date:  2022-05-03       Impact factor: 6.709

3.  Sevoflurane Induces Ferroptosis of Glioma Cells Through Activating the ATF4-CHAC1 Pathway.

Authors:  Yingyi Xu; Na Zhang; Cheng Chen; Xinke Xu; Ailing Luo; Yaping Yan; Yanhua Lu; Jianhua Liu; Xinxu Ou; Yonghong Tan; Yufeng Liang; Lihe Chen; Xingrong Song; Xiaoping Liu
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 4.  Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.

Authors:  Yu Meng; Huiyan Sun; Yayun Li; Shuang Zhao; Juan Su; Furong Zeng; Guangtong Deng; Xiang Chen
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

Review 5.  Ferroptosis is involved in regulating perioperative neurocognitive disorders: emerging perspectives.

Authors:  Yanhong Song; Ziyi Wu; Hang Xue; Ping Zhao
Journal:  J Neuroinflammation       Date:  2022-09-06       Impact factor: 9.587

6.  Identification and Validation of Ferroptosis-Related Genes in Sevoflurane-Induced Hippocampal Neurotoxicity.

Authors:  Mengrong Miao; Yangyang Wang; Shuang Zeng; Yaqian Han; Ruilou Zhu; Pengfei Yu; Yitian Yang; Ningning Fu; Ningning Li; Mingyang Sun; Jiaqiang Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.